Sihuan

Sihuan

Postby helios » Sat May 17, 2008 4:15 pm

since its IPO days, i have not been conscientiously updating myself on this stock; ie. from their recent upside since late march, e chart movements have been uptrending since march-20 (its record L: 0.515?) w e inverse hammer position amidst uncertain moments in march, however e volume signal is not strong, indicating not much participative interest fr e local market.

e latest updates announcements include:

1. 14may: PR strategy to ride on crisis news: in kind donations for e sizhuan victims: Beijing Sihuan Pharmaceutical Co., Ltd, has donated RMB1 million (cash) + RMB2 million worth of life-saving drugs, e.g. Naloxone to the Beijing Red Cross.

2. 15may: acquisition deal: 45% of Beijing Purenhong Pharmaceutical Co Ltd (北京普仁鸿医药销售有限公司) largest privately owned pharmaceutical products distribution company for RMB 50.7 million.

while e stock is currently downtrending w e indicators, who knows if it posed another buying opportunity?
Last edited by helios on Sat Oct 11, 2008 11:09 am, edited 3 times in total.
[Finance disclaimer: The content of this article is intended to provide a general guide to the subject matter. Specialist advice should be sought regarding investing of any stocks/ funds and/or whatsoever. The author has no vested interest in the mentioned stock at the time of writing.
helios
Permanent Loafer
 
Posts: 3608
Joined: Wed May 07, 2008 8:30 am

Re: Sihuan

Postby winston » Sat May 17, 2008 9:15 pm

Hi San,

The following are some Target Price that I have on this counter:-
1) Phillips 1.35 Feb 26 Jan 14 Nov 7 from 1.33 Oct 11 Aug 8 from 1.02 May 15 from 0.965 Apr 3
2) Daiwa 1.43 Apr 10 from 1.25 Oct 10 from 0.90 May 23

Take care,
Winston
It's all about "how much you made when you were right" & "how little you lost when you were wrong"
User avatar
winston
Billionaire Boss
 
Posts: 118528
Joined: Wed May 07, 2008 9:28 am

Re: Sihuan

Postby winston » Fri May 23, 2008 4:19 pm

Che FengSheng bought 2 mln, and Guo Weicheng bought 400,000 SIHUAN PHARMA shares
at 91.1 cents and 90.9 cents each, raising their respective direct holdings to 3.03 mln shares and
400,000 shares.

Plenty Gold Enterprises, which is owned 51% by Che (Chairman/CEO) and 49% by Guo (Vice Chairman), owns 350 mln shares.
It's all about "how much you made when you were right" & "how little you lost when you were wrong"
User avatar
winston
Billionaire Boss
 
Posts: 118528
Joined: Wed May 07, 2008 9:28 am

Re: Sihuan

Postby helios » Thu Jul 03, 2008 8:57 pm

>>> this's e Co. i like ... didn't get my IPO bid that time, coz only 5Mil for public;
>>> here's e good news: Sihuan wins RMB2.6 bln R&D grant to develop drug:

3. Sihuan Pharmaceutical Holdings Group announced that wholly owned Beijing Sihuan Pharmaceutical Co., Ltd (Beijing Sihuan) has won yet another R&D grant, worth RMB2.6 million, from the Beijing Municipal Science and Technology Commission (北京市科学技术委员会), to conduct clinical research on a CV drug named piperphentonamine hydrochloride (PPTA).

PPTA is classified as a Category 1* drug and is the first of its kind to be developed in the PRC for use in strengthening and protecting the heart. This is Beijing Sihuan’s second research project to receive an R&D grant from the Commission. In 2006 and 2007, it clinched a combined R&D grant of RMB1.5 million from the Commission to carry out pre-clinical research on a coronary heart disease treatment drug called G20.

>>> TOL: pre-clinical research means animal trials ...
>>> e active ingredients r plant extracts based-formular ... mmm ... plant patents r generally disputable ...

Category 1: refers to newly discovered medicines/ new pharmaceutical constituents of medicines whose effective ingredients and preparations are extracted from plants, animals and minerals that have not yet been marketed in the PRC. These medicines are usually substitutes for Chinese herbs and conform to existing state drug standards.
[Finance disclaimer: The content of this article is intended to provide a general guide to the subject matter. Specialist advice should be sought regarding investing of any stocks/ funds and/or whatsoever. The author has no vested interest in the mentioned stock at the time of writing.
helios
Permanent Loafer
 
Posts: 3608
Joined: Wed May 07, 2008 8:30 am

Re: Sihuan BL5

Postby helios » Fri Jul 18, 2008 9:10 am

4. 9-july announcements: (Shenzhen Sihuan) has secured the exclusive rights to distribute a high-quality amino acid injection in the PRC for a period of five years. Named Luoanming (洛安命), the nutritional drug is used to enhance the recovery of patients after injury or surgery. Luoanming is purer than alternatives sold in the market as it is made from superior raw materials imported directly from Japan and Western countries. It also possesses higher efficacy than cheaper rival substitutes such as glucose infusions. Currently, there are no similar products whose raw materials are sourced from overseas.
[Finance disclaimer: The content of this article is intended to provide a general guide to the subject matter. Specialist advice should be sought regarding investing of any stocks/ funds and/or whatsoever. The author has no vested interest in the mentioned stock at the time of writing.
helios
Permanent Loafer
 
Posts: 3608
Joined: Wed May 07, 2008 8:30 am

Re: Sihuan BL5

Postby iam802 » Mon Jul 21, 2008 7:16 pm

potential bullish reversal ? or it could fall below the moving average ...?

Image
1. Always wait for the setup. NO SETUP; NO TRADE

2. The trend will END but I don't know WHEN.

TA and Options stuffs on InvestIdeas:
The Ichimoku Thread | Option Strategies Thread | Japanese Candlesticks Thread
User avatar
iam802
Big Boss
 
Posts: 6353
Joined: Wed May 07, 2008 1:14 am

Re: Sihuan BL5

Postby millionairemind » Sat Aug 02, 2008 8:30 pm

Sihuan’s 1H08 Profit Before Tax Jumps 65%

Mainboard-listed Sihuan Pharmaceutical Holdings, a leading manufacturer of cardiocerebral vascular drugs in China, delivered yet another impressive set of results for the first half-year ended 30 June 2008 (1H08). Its profit before tax was Rmb127.9m in 1H08, up 65% a year ago, as the Group enjoyed robust demand for a broad range of its drugs. Its net attributable profit surged 37% to Rmb113.8m. Sihuan’s strategic marketing efforts to penetrate niche but high-margin segments have clearly paid off, drawing in Rmb69m in additional revenues. This, together with the Group’s extensive range of non-CV products, largely from Shenzhen Sihuan Pharmaceutical, powered a 104% hike in Sihuan’s 1H08 revenue to Rmb237.3m, up from Rmb116.4m a year ago. Shenzhen Sihuan recorded a net profit of Rmb9.5m on sales of Rmb52.0m in 1H08.
"If a speculator is correct half of the time, he is hitting a good average. Even being right 3 or 4 times out of 10 should yield a person a fortune if he has the sense to cut his losses quickly on the ventures where he has been wrong" - Bernard Baruch

Disclaimer - The author may at times own some of the stocks mentioned in this forum. All discussions are NOT to be construed as buy/sell recommendations. Readers are advised to do their own research and analysis.
User avatar
millionairemind
Big Boss
 
Posts: 8183
Joined: Wed May 07, 2008 8:50 am
Location: The Matrix

Re: Sihuan BL5

Postby helios » Sat Aug 02, 2008 9:32 pm

daily chart, 31-july & 01-aug candles show bearish engulfment with %K lowering; weekly chart looks undecided entry. moving avg looks stuck to me ... and the volume interest is very thin since late-May period ... see if it comes <0.75?

Ref. ipo price was 0.63? can't remember. Q for it, didn't get it.

be patient ...
[Finance disclaimer: The content of this article is intended to provide a general guide to the subject matter. Specialist advice should be sought regarding investing of any stocks/ funds and/or whatsoever. The author has no vested interest in the mentioned stock at the time of writing.
helios
Permanent Loafer
 
Posts: 3608
Joined: Wed May 07, 2008 8:30 am

Re: Sihuan BL5

Postby millionairemind » Mon Aug 25, 2008 8:24 am

From BT Times today
Sihuan Pharmaceutical

Purchases by deputy chairman Guo Weicheng in cardiocerebral vascular drugs developer and manufacturer Sihuan Pharmaceutical Holdings so far this month totalling 461,000 shares accounted for 41 per cent of the stock's trading volume. The acquisitions were made from August 8 to 19 at an average of 76 cents each. Mr Guo last bought 310,000 shares on August 19 at 78 cents each, which increased his holdings (direct & deemed) to 331.8 million shares or 70.6 per cent. Prior to the trades this month, the deputy chairman purchased 450,000 shares on June 19 at 82 cents each and 400,000 shares on May 20 at 91 cents each. The stock closed at 77 cents on Friday.
"If a speculator is correct half of the time, he is hitting a good average. Even being right 3 or 4 times out of 10 should yield a person a fortune if he has the sense to cut his losses quickly on the ventures where he has been wrong" - Bernard Baruch

Disclaimer - The author may at times own some of the stocks mentioned in this forum. All discussions are NOT to be construed as buy/sell recommendations. Readers are advised to do their own research and analysis.
User avatar
millionairemind
Big Boss
 
Posts: 8183
Joined: Wed May 07, 2008 8:50 am
Location: The Matrix

Sihuan

Postby stilicon » Mon May 25, 2009 8:18 pm

a) SIHUAN (BL5 on SGX) had a more than decent FY2008, with net result increasing +30/+35%, and operating result about +50%, operating cash-flow + 30%. 1st quarter results were also good. It has no debt, no shrinking market as many others are or will be experiencing soon. The management seems prudent, honest and competent (But this, I wish I knew more about it). At least, it continues to pay a decent dividend, which is always a sign of respect for shareholders. No vicious script-scheme here (at least until now). (I won't dwel on the FA, for people can do it themselves / or always argue rather indecisively (and stupidly).)
So, present valuation is not demanding. Few people posted about this, either here or through the "super-analysts" of CIMB, DBS, OCBC and Co (although I am always happy to read them ...)

b) I don't see any reason why the future of pharmaceutical lab. in China should be seriously impacted by the current Global Recession, except through relatively minor indirects ways.

c) SIHUAN during the last two years has always been undervalued compared to similar/bigger companies listed on HK, but rose with a few months delay. Take for example and comparison SINO BIOPHARMA (1177 on HKEx). During the last 5/6 month, this latter company surged (about 85% in 6 months). In comparison, SIHUAN move about +35%. (and the SGD/HKD doesn't explain such a discrepancy alone, by far).
The results for FY2008 of SINO BIOPHARMA were merely good or correct (except for operating cash-flows which were a big +, but again, no detailled FA here).

=>My point is : from an investment point of view (I don't do trading on SGX, being too far away), SIHUAN is one the best value propositions I see, now that so many things have gone so wildly up in the last two months.

To me, the future of SIHUAN is
a) it continues to develop as today and the past few years, and treat its shareholders well with fairly decent and hopefully increasing dividends, or
b) sometime in the future, get purchased by a bigger fish (fine by me).

I would welcome contradiction and opposite views on this co.
stilicon
Coolie
 
Posts: 201
Joined: Fri Sep 12, 2008 5:21 pm

Next

Return to S to T

Who is online

Users browsing this forum: No registered users and 10 guests

cron